Concurrent mutation in exons 1 and 2 of the K-ras oncogene in colorectal cancer

Folia Histochemica et Cytobiologica

Volumn 49, Issue 4, 2011, Pages 729-733

  Palmirotta, Raffaele ^a   Savonarola, Annalisa ^a   Ludovici, Giorgia ^a   de Marchis, Maria Laura ^a   Covello, Renato ^b   Ettorre, Giuseppe Maria ^c   Ialongo, Cristiano ^a   Guadagni, Fiorella ^a  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Colorectal cancer; Double mutation; K ras

Indexed keywords

AGED; ARTICLE; CASE REPORT; CODON; COLORECTAL CANCER; DOT HYBRIDIZATION; EXON; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MALE; ONCOGENE K RAS; POINT MUTATION; SIGNAL TRANSDUCTION;

EID: 84856809551     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2011.0097     Document Type: Article

References (22)

1. van Krieken JH, Jung A, Kirchner T et al. K-RAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch. 2008;453:417-423.
2. Andreyev HJ, Norman AR, Cunningham D, Oates JR, Clarke PA. Kirsten ras mutations in patients with colorectal cancer: the multicenter 'RASCAL' study. J Natl Cancer Inst. 1998;90:675-684.
3. Martinez-Garza SG, Nunez-Salazar A, Calderon-Garciduenas AL, Bosques-Padilla FJ, Niderhauser-Garcia A, Barrera- -Saldana HA. Frequency and clinicopathology associations of K-ras mutations in colorectal cancer in a northeast Mexican population. Dig Dis. 1999;17:225-229.
4. Urosevic N, Krtolica K, Skaro-Milic A, Knezevic-Usaj S, Dujic A. Prevalence of G-to-T transversions among K-ras oncogene mutations in human colorectal tumors in Yugoslavia. Int J Cancer. 1993;54:249-254.
5. Breivik J, Meling GI, Spurkland A, Rognum TO, Gaudernack G. K-ras mutation in colorectal cancer: relations to patient age, sex and tumor location. Br J Cancer. 1994;69:367-371.
6. Hongyo T, Buzard GS, Palli D et al. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Cancer Res. 1995;55: 2665-2672.
7. Palmirotta R, Savonarola A, Formica V et al. A novel K-ras mutation in colorectal cancer. A case report and literature review. Anticancer Res. 2009;29:3369-3374.
8. Miyakura Y, Sugano K, Fukayama N, Konishi F, Nagai H. Concurrent mutations of K-ras oncogene at codons 12 and 22 in colon cancer. Jpn J Clin Oncol. 2002;32:219-221.
9. Naguib A, Mitrou PN, Gay LJ et al. Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study. BMC Cancer. 2010;10:99.
10. Sato S, Ito K, Ozawa N, Yajima A, Sasano H. Analysis of Point Mutations at Codon 12 of K-ras in Human Endometrial Carcinoma and Cervical Adenocarcinoma by Dot Blot Hybridization and Polymerase Chain Reaction. Tohoku J Exp Med. 1991;165:131-136.
11. Khanna M, Park P, Zirvi M et al. Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors. Oncogene. 1999;18:27-38.
12. Jönsson M, Ekstrand A, Edekling T et al. Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor. BMC Clin Pathol. 2009;9:8.
13. Hong HH, Houle CD, Ton TV, Sills RC. K-ras Mutations in lung tumors and tumors from other organs are consistent with a common mechanism of ethylene oxide tumorigenesis in the B6C3F1 mouse. Toxicol Pathol. 2007;35:81-85.
14. Guo Z, Lu Y, Oakes S et al. Transnational patterns of pancreas cancer Ras mutations and discovery of a new Ras mutation with oncogenic synergy when found with Ras codon 12 mutations. AACR-NCI-EORTC Poster presentation.# 22; 2008.
15. Kimura K, Nagasaka T, Hoshizima N et al. No duplicate K-RAS mutation is identified on the same allele in gastric or colorectal cancer cells with multiple K-RAS mutations. J Int Med Res. 2007;35:450-457.
16. Sugio K, Inoue T, Inoue K et al. Different site mutation of the K-ras gene in a patient with metachronous double lung cancers. Anticancer Res. 1993;13:2469-2471.
17. Ahuja HG, Foti A, Bar-Eli M, Cline MJ. The pattern of mutational involvement of RAS genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood. 1990;75:1684-1690.
18. Gu Q, Li L, Zhang Y, Li X, Xiao Y, Wu X. Sequencing analysis of human K-ras oncogene exon 1 in Chinese people. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 1998;15:98-100.
19. Zaravinos A, Bizakis J, Soufla G, Sourvinos G, Spandidos DA. Mutations and differential expression of the ras family genes in human nasal polyposis. Int J Oncol. 2007;31:1051-1059.
20. Sakaue H, Ogawa W, Takata M et al. Phosphoinositide 3-kinase is required for insulin-induced but not for growth hormone- or hyperosmolarity-induced glucose uptake in 3T3-L1 adipocytes. Mol Endocrinol. 1997;11:1552-1562.
21. Sun X, Bognar AL, Baker EN, Smith CA. Structural homologies with ATP- and folate-binding enzymes in the crystal structure of folylpolyglutamate synthetase. Proc Natl Acad Sci USA. 1998;95:6647-6652.
22. Sweeney C, Boucher KM, Samowitz WS et al. Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors. Genes, Chromosomes & Cancer. 2009;48:1-9.